Atropine Sulfate Injection (Canada)

This page contains information on Atropine Sulfate Injection for veterinary use.
The information provided typically includes the following:
  • Atropine Sulfate Injection Indications
  • Warnings and cautions for Atropine Sulfate Injection
  • Direction and dosage information for Atropine Sulfate Injection

Atropine Sulfate Injection

This treatment applies to the following species:
Manufacturer: Bimeda-MTC

Atropine Sulfate Injection, USP

DIN 00715492

Sterile

Veterinary Use Only

Warning

KEEP OUT OF REACH OF CHILDREN.

Active Ingredient

Atropine sulfate 0.5 mg per mL.

Preservative: Benzyl Alcohol 1.5% w/v

Atropine Sulfate Injection Indications

Anticholinergic, Antispasmodic.

To be used as an aid in controlling excessive bronchial secretions, excessive gastric secretions, hypermotility of intestinal smooth muscle and excessive salivation in horses, cattle, swine, dogs and cats.

DOSAGE: Average dose is 0.04 mg/kg body weight administered by intravenous, intramuscular or subcutaneous injection.

Contraindications

Do not use in animals with glaucoma.

Storage

Store at room temperature (15°C to 30°C).

Manufactured by: Bimeda-MTC Animal Health Inc., Cambridge ON, N3C 2W4

Net

 

30 mL

8ATRO06

NAC No.: 14730020

BIMEDA-MTC ANIMAL HEALTH INC.
420 BEAVERDALE ROAD, CAMBRIDGE, ON, N3C 2W4
Telephone:   519-654-8000
Website:   www.bimedamtc.com
Every effort has been made to ensure the accuracy of the Atropine Sulfate Injection information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-04-11

(web1)